News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
533 Results
Type
Article (44)
Company Profile (1)
Press Release (488)
Section
Business (172)
Deals (27)
Drug Development (133)
FDA (6)
Job Trends (5)
News (324)
Policy (27)
Tag
Alliances (40)
Antibody-drug conjugate (ADC) (1)
Approvals (6)
Best Places to Work (6)
Biotechnology (1)
Cancer (2)
Career advice (1)
Cell therapy (2)
Clinical research (111)
Collaboration (1)
Compensation (1)
COVID-19 (2)
C-suite (2)
Diabetes (1)
Drug pricing (1)
Earnings (62)
Events (82)
Executive appointments (3)
FDA (10)
Funding (5)
GLP-1 (2)
Government (1)
Guidances (1)
Immunology and inflammation (4)
Infectious disease (2)
Inflammatory bowel disease (3)
IPO (16)
Job creations (2)
Leadership (1)
Legal (1)
Manufacturing (1)
Medical device (4)
Medtech (5)
Mergers & acquisitions (14)
Metabolic disorders (3)
NextGen: Class of 2026 (7)
Obesity (2)
People (58)
Phase 1 (18)
Phase 2 (63)
Phase 3 (44)
Pipeline (6)
Postmarket research (3)
Preclinical (12)
Real estate (1)
Regulatory (31)
Research institute (1)
Series A (3)
Series B (1)
Startups (10)
The Weekly (1)
Vaccines (4)
Venture capital (1)
Weight loss (1)
Date
Last 7 days (2)
Last 30 days (4)
Last 365 days (22)
2026 (5)
2025 (19)
2024 (34)
2023 (37)
2022 (36)
2021 (31)
2020 (41)
2019 (36)
2018 (19)
2017 (33)
2016 (21)
2015 (26)
2014 (24)
2013 (38)
2012 (35)
2011 (31)
2010 (27)
Location
Asia (18)
Australia (3)
California (10)
Canada (2)
China (2)
Europe (33)
Indiana (5)
Massachusetts (19)
Nevada (1)
New York (2)
Northern California (5)
Pennsylvania (1)
South America (1)
Southern California (5)
United States (35)
533 Results for "morphic therapeutic.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Morphic Medical Announces CEO Transition
August 6, 2025
·
3 min read
Press Releases
Morphic Medical Announces CE Mark for RESET® Endoscopic Device Therapy
July 8, 2025
·
4 min read
Genetown
Morphic to Participate in Jefferies Global Healthcare Conference
Morphic Therapeutic today announced that members of its management team will take part in a fireside chat at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5th, at 10:30 AM ET.
May 31, 2024
·
1 min read
Business
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
Morphic Therapeutic today reported corporate highlights and financial results for the first quarter 2024.
April 25, 2024
·
9 min read
Business
Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio
Eli Lilly on Monday announced a $3.2 billion all-cash deal to purchase Morphic and its pipeline of oral integrin therapies in a move to expand the pharma’s presence in the autoimmune diseases space.
July 8, 2024
·
2 min read
·
Tristan Manalac
Genetown
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
Morphic Therapeutic announced that Dr. Marc Schegerin, COO and CFO, will take part in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15th, at 9:00 AM ET.
May 9, 2024
·
1 min read
Business
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
Morphic Therapeutic today announced that Simon Cooper, M.B.B.S., has joined the Company as Chief Medical Officer.
March 19, 2024
·
5 min read
Genetown
Morphic to Participate in March 2024 Investor Conferences
Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, announced its participation at investor conferences during the month of March.
March 5, 2024
·
1 min read
Genetown
Morphic to Present at November 2023 Investor Conferences
Morphic Therapeutic announced that its management team will participate in the upcoming Jefferies London Healthcare Conference and Evercore ISI HealthCONx Conference.
November 10, 2023
·
1 min read
Business
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the full year 2023.
February 22, 2024
·
12 min read
1 of 54
Next
